Prolia 60 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FT5FU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,181
Award facts
- Contract value 100% obligated
- $13,180.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,180.79 to AmerisourceBergen Drug Corp for PROLIA 60 MG/ML Syringe on January 9, 2026, with a completion date of January 12, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems with an extensive portfolio of pharmaceutical products and medical supplies.
This delivery order is executed under AmerisourceBergen's significant $999,999,999.00 IDC with DLA Troop Support Medical, which extends through December 2026 and functions as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical devices to support military healthcare programs worldwide. PROLIA, a bone health medication, aligns with the company's established role in delivering specialized pharmaceutical commodities across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT5FU?
SPE2DR26FT5FU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FT5FU worth?
The government has obligated $13,181 on SPE2DR26FT5FU.
Is contract SPE2DR26FT5FU an order under another contract?
Yes. SPE2DR26FT5FU is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5FU competed?
The extent of competition for SPE2DR26FT5FU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award